Changes in Statin Use Among U.S. Adults With Diabetes: A Population-Based Analysis of NHANES 2011-2018.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
17
06
2020
accepted:
17
09
2020
pubmed:
7
10
2020
medline:
29
5
2021
entrez:
6
10
2020
Statut:
ppublish
Résumé
To evaluate statin use in the U.S. before and after the 2015 American Diabetes Association position statement, which expanded statin therapy recommendations to include all adults 40-75 years old with diabetes. The National Health and Nutrition Examination Survey (NHANES) was used to obtain a representative sample. The difference-in-differences technique determined the impact of the recommendation on the proportion of people with diabetes for whom statin therapy was newly recommended. Among people with diabetes, the change in statin use in people without atherosclerotic cardiovascular disease (ASCVD) risk factors, controlling for change among people with ASCVD/risk factors, was 6.6% ( The most recent change in statin recommendations had minimal impact on the proportion of patients receiving a statin.
Identifiants
pubmed: 33020050
pii: dc20-1481
doi: 10.2337/dc20-1481
doi:
Substances chimiques
Hydroxymethylglutaryl-CoA Reductase Inhibitors
0
Banques de données
figshare
['10.2337/figshare.12982367']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
3110-3112Informations de copyright
© 2020 by the American Diabetes Association.